Active	Status	Sponsor type	Region	Phase	Filter
13 Active 2 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

13 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Schaenman, Joanna
NCT06263426: Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)	Recruiting	N/A	200	US	HIV D+/R+, HIV D-/R+	Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID)	Hiv	09/28	09/29
Huang, Edmund
SAFE KIDNEY II, NCT05769582: Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients	Recruiting	2/3	180	US	Anti-BK polyomavirus (AntiBKV)	Memo Therapeutics AG	BK Viremia; BKV DNAemia	11/24	11/24
NCT03859388: Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection	Active, not recruiting	N/A	10	US		Cedars-Sinai Medical Center	Rejection Chronic Renal, Kidney Transplant Rejection	12/24	12/24
KOAR, NCT03326076: Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry	Active, not recruiting	N/A	4000	US	Donor-derived cell-free DNA (AlloSure®), Standard care, Peripheral blood gene expression profiling (AlloMap Kidney), Analytic platform (IBox)	CareDx	Kidney Transplant Rejection	06/25	12/25
Pham, Phuong-Thu
APPELHUS, NCT04889430 / 2020-005186-13: Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy	Recruiting	3	50	Europe, Japan, US, RoW	Iptacopan, LNP023	Novartis Pharmaceuticals, Novartis Pharma AG	Atypical Hemolytic Uremic Syndrome	09/28	03/29
Bunnapradist, Suphamai
NCT02866682: Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients	Completed	4	176	US	Prograf, Tacrolimus	University of California, Los Angeles, Food and Drug Administration (FDA)	Renal Transplant Rejection	06/21	06/21
GOOD-IDES-02, NCT05679401: A Study With Imlifidase in Anti-GBM Disease	Active, not recruiting	3	50	Europe, US, RoW	Imlifidase, IdeS, HMED-IdeS, Plasma exchange (PLEX), PE, Cyclophosphamide (CYC), Glucocorticoids	Hansa Biopharma AB	Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome, Good Pasture Syndrome	06/25	11/26
SAFE KIDNEY II, NCT05769582: Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients	Recruiting	2/3	180	US	Anti-BK polyomavirus (AntiBKV)	Memo Therapeutics AG	BK Viremia; BKV DNAemia	11/24	11/24
NCT05917522: Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation	Recruiting	2	800	US	Abatacept, Orencia, Standard of Care at US Transplant Centers	National Institute of Allergy and Infectious Diseases (NIAID)	Kidney Transplant	07/27	07/29
KOAR, NCT03326076: Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry	Active, not recruiting	N/A	4000	US	Donor-derived cell-free DNA (AlloSure®), Standard care, Peripheral blood gene expression profiling (AlloMap Kidney), Analytic platform (IBox)	CareDx	Kidney Transplant Rejection	06/25	12/25
ProActive, NCT04091984: The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry	Active, not recruiting	N/A	5000	US	Prospera	Natera, Inc., University of Maryland	Kidney Transplant Rejection	10/26	10/27
Gadzhyan, Janette
KOAR, NCT03326076: Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry	Active, not recruiting	N/A	4000	US	Donor-derived cell-free DNA (AlloSure®), Standard care, Peripheral blood gene expression profiling (AlloMap Kidney), Analytic platform (IBox)	CareDx	Kidney Transplant Rejection	06/25	12/25
Datta, Nakul
SAFE KIDNEY II, NCT05769582: Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients	Recruiting	2/3	180	US	Anti-BK polyomavirus (AntiBKV)	Memo Therapeutics AG	BK Viremia; BKV DNAemia	11/24	11/24
Abdalla, Basmah
No trials found
Sampaio, Marcelo
No trials found